RxSight面临关于产品需求和财务业绩的误导性陈述指控的集体诉讼。 RxSight faces class action lawsuit over alleged misleading statements on product demand and financial performance.

对RxSight公司及其官员提起了集体诉讼,指控他们从2024年11月7日到2025年7月8日作了误导性陈述,隐瞒了有关该公司业务和经营的问题。 A class action lawsuit has been filed against RxSight, Inc. and its officers, alleging they made misleading statements and concealed issues about the company's business and operations from Nov. 7, 2024, to July 8, 2025. 诉讼要求 " RxSight " 高报了产品需求,未能达到财务目标,导致销售量下降。 The lawsuit claims RxSight overstated product demand and failed to meet financial targets, leading to declines in sales. 鼓励在此期间购买证券并蒙受损失的投资者加入该案。 Investors who purchased securities during this period and suffered losses are encouraged to join the case.